Efficacy and safety of telitacicept in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial.
Dong XuJianmin FangShangzhu ZhangCibo HuangChenghui HuangLi QinXiaomei LiMeiqing ChenXiumei LiuYi LiuZhijun LiJiankang HuChunde BaoWei WeiJing TianXinwang DuanXiaofeng ZengPublished in: Rheumatology (Oxford, England) (2023)
ClinicalTrials.gov, https://clinicaltrials.gov, NCT04078386.